Research ExplorerPublicationsCancer care in German centers of excellence during the first...

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

Standard

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. / Arndt, Volker; Doege, Daniela; Fröhling, Stefan; Albers, Peter; Algül, Hana; Bargou, Ralf; Bokemeyer, Carsten; Bornhäuser, Martin; Brandts, Christian H; Brossart, Peter; Brucker, Sara Yvonne; Brümmendorf, Tim H; Döhner, Hartmut; Gattermann, Norbert; Hallek, Michael; Heinemann, Volker; Keilholz, Ulrich; Kindler, Thomas; von Levetzow, Cornelia; Lordick, Florian; Neumann, Ulf Peter; Peters, Christoph; Schadendorf, Dirk; Stilgenbauer, Stephan; Zander, Thomas; Zips, Daniel; Braun, Delia; Seufferlein, Thomas; Nettekoven, Gerd; Baumann, Michael.

In: J CANCER RES CLIN, Vol. 149, No. 2, 02.2023, p. 913-919.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Arndt, V, Doege, D, Fröhling, S, Albers, P, Algül, H, Bargou, R, Bokemeyer, C, Bornhäuser, M, Brandts, CH, Brossart, P, Brucker, SY, Brümmendorf, TH, Döhner, H, Gattermann, N, Hallek, M, Heinemann, V, Keilholz, U, Kindler, T, von Levetzow, C, Lordick, F, Neumann, UP, Peters, C, Schadendorf, D, Stilgenbauer, S, Zander, T, Zips, D, Braun, D, Seufferlein, T, Nettekoven, G & Baumann, M 2023, 'Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic', J CANCER RES CLIN, vol. 149, no. 2, pp. 913-919. https://doi.org/10.1007/s00432-022-04407-1

APA

Arndt, V., Doege, D., Fröhling, S., Albers, P., Algül, H., Bargou, R., Bokemeyer, C., Bornhäuser, M., Brandts, C. H., Brossart, P., Brucker, S. Y., Brümmendorf, T. H., Döhner, H., Gattermann, N., Hallek, M., Heinemann, V., Keilholz, U., Kindler, T., von Levetzow, C., ... Baumann, M. (2023). Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. J CANCER RES CLIN, 149(2), 913-919. https://doi.org/10.1007/s00432-022-04407-1

Vancouver

Arndt V, Doege D, Fröhling S, Albers P, Algül H, Bargou R et al. Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. J CANCER RES CLIN. 2023 Feb;149(2):913-919. https://doi.org/10.1007/s00432-022-04407-1

Bibtex

@article{ac638a3f14424f9294a1a06ec77b5612,
title = "Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic",
abstract = "PURPOSE: An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic.METHODS: Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022.RESULTS: The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (- 21%) and psycho-oncologic care (- 12%), but also tumor surgery (- 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care.CONCLUSIONS: This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.",
author = "Volker Arndt and Daniela Doege and Stefan Fr{\"o}hling and Peter Albers and Hana Alg{\"u}l and Ralf Bargou and Carsten Bokemeyer and Martin Bornh{\"a}user and Brandts, {Christian H} and Peter Brossart and Brucker, {Sara Yvonne} and Br{\"u}mmendorf, {Tim H} and Hartmut D{\"o}hner and Norbert Gattermann and Michael Hallek and Volker Heinemann and Ulrich Keilholz and Thomas Kindler and {von Levetzow}, Cornelia and Florian Lordick and Neumann, {Ulf Peter} and Christoph Peters and Dirk Schadendorf and Stephan Stilgenbauer and Thomas Zander and Daniel Zips and Delia Braun and Thomas Seufferlein and Gerd Nettekoven and Michael Baumann",
note = "{\textcopyright} 2022. The Author(s).",
year = "2023",
month = feb,
doi = "10.1007/s00432-022-04407-1",
language = "English",
volume = "149",
pages = "913--919",
journal = "J CANCER RES CLIN",
issn = "0171-5216",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

AU - Arndt, Volker

AU - Doege, Daniela

AU - Fröhling, Stefan

AU - Albers, Peter

AU - Algül, Hana

AU - Bargou, Ralf

AU - Bokemeyer, Carsten

AU - Bornhäuser, Martin

AU - Brandts, Christian H

AU - Brossart, Peter

AU - Brucker, Sara Yvonne

AU - Brümmendorf, Tim H

AU - Döhner, Hartmut

AU - Gattermann, Norbert

AU - Hallek, Michael

AU - Heinemann, Volker

AU - Keilholz, Ulrich

AU - Kindler, Thomas

AU - von Levetzow, Cornelia

AU - Lordick, Florian

AU - Neumann, Ulf Peter

AU - Peters, Christoph

AU - Schadendorf, Dirk

AU - Stilgenbauer, Stephan

AU - Zander, Thomas

AU - Zips, Daniel

AU - Braun, Delia

AU - Seufferlein, Thomas

AU - Nettekoven, Gerd

AU - Baumann, Michael

N1 - © 2022. The Author(s).

PY - 2023/2

Y1 - 2023/2

N2 - PURPOSE: An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic.METHODS: Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022.RESULTS: The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (- 21%) and psycho-oncologic care (- 12%), but also tumor surgery (- 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care.CONCLUSIONS: This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.

AB - PURPOSE: An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic.METHODS: Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022.RESULTS: The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (- 21%) and psycho-oncologic care (- 12%), but also tumor surgery (- 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care.CONCLUSIONS: This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.

U2 - 10.1007/s00432-022-04407-1

DO - 10.1007/s00432-022-04407-1

M3 - SCORING: Journal article

C2 - 36241862

VL - 149

SP - 913

EP - 919

JO - J CANCER RES CLIN

JF - J CANCER RES CLIN

SN - 0171-5216

IS - 2

ER -